Group 1 - Oppenheimer Holdings (OPY) reported a strong quarter, benefiting from relatively fixed costs and operating leverage across its segments [2] - Wealth management performed well due to higher Assets Under Management (AUM) and increased market valuations [2] - The Valkyrie Trading Society is a team of analysts focused on high conviction, obscure developed market ideas that are expected to yield non-correlated and outsized returns in the current economic environment [2] Group 2 - The Value Lab is an investment group that targets long-only value ideas, aiming for a portfolio yield of approximately 4% [1] - The Value Lab provides members with real-time updates, 24/7 chat support, regular global market news reports, feedback on stock ideas, monthly new trades, quarterly earnings write-ups, and daily macro opinions [2]

Exhibit 99.1 Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings New York, January 30, 2026 – Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 mi ...

NEW YORK, Jan. 30, 2026 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%. For the year ended D ...

Group 1 - M-tron Industries, Inc. will host virtual 1x1 meetings with investors at the Oppenheimer 11 Annual Emerging Growth Conference on February 3, 2026 [1] - The company expresses appreciation for Oppenheimer & Co. Inc.'s support and the opportunity to engage with investors [1] Group 2 - M-tron Industries, Inc. designs, manufactures, and markets high-reliability frequency and spectrum control products and solutions [2] - The company provides comprehensive support throughout the product life cycle, including design, prototyping, production, and upgrades [2] - M-tron has facilities in Orlando, Florida, Yankton, South Dakota, a sales office in Hong Kong, and a manufacturing facility in Noida, India [2]

Group 1 - Oppenheimer upgraded Relay Therapeutics Inc. (RLAY) to Outperform from Perform, resulting in a significant increase in stock price since the upgrade on the 26th [1] - The stock price of Relay Therapeutics has seen a considerable boost following the upgrade, indicating positive market sentiment [1] Group 2 - The focus of the analysis is on identifying promising biotechnology companies that are innovating through unique mechanisms of action, first-in-class therapies, or platform technologies [1] - The approach emphasizes evaluating the science behind drug candidates, the competitive landscape, clinical trial design, and potential market opportunities while balancing financial fundamentals and valuation [1]

FREMONT, CA / ACCESS Newswire / January 27, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), data center, automotive, and industrial applications, today announced it will participate in the Oppenheimer 11th Annual Emerging Growth Conference being held virtually February 3-4, 2026. Aehr Test CEO Gayn Erickson and CFO Chris Siuwill be hosting virtual meetings with investors throughout the day on Tuesday, Fe ...

Core Insights - American Public Education, Inc. (APEI) is participating in the Oppenheimer 11th Annual Emerging Growth Conference on February 3-4, 2026, with key executives including CEO Angela Selden and CFO Edward Codispoti [1] Company Overview - APEI provides online and campus-based postsecondary education to approximately 109,000 students, aiming to transform lives, advance careers, and improve communities [1][3] - The company operates through three main institutions: American Public University System (APUS), Rasmussen University, and Hondros College of Nursing [3] Institutional Details - APUS serves around 88,700 adult learners globally, focusing on active-duty military and veteran students, and is recognized as a leading educator in this sector [4][7] - Rasmussen University, with a history of 125 years, caters to approximately 15,900 students across 20 campuses in six states and online, offering programs in nursing, health sciences, business, technology, design, early childhood education, and justice studies [5] - Hondros College of Nursing is the largest educator of Practical Nurses (LPN) in Ohio, serving about 4,000 students across eight campuses [6][8] Accreditation - APUS and Rasmussen University are accredited by the Higher Learning Commission (HLC), while Hondros College of Nursing is accredited by the Accrediting Bureau of Health Education Schools (ABHES) [7]

Core Insights - Oppenheimer & Co. Inc. has strengthened its Biotech Research Team by hiring Kostas Biliouris as Managing Director, enhancing its long-standing expertise in the biotech sector [1][3] - Biliouris brings extensive experience from BMO Capital Markets and Morgan Stanley, along with a Ph.D. in biochemical engineering, which will contribute to Oppenheimer's research capabilities in genetic medicines and biotech [2][3] - The firm aims to expand its research coverage in biotech, an area characterized by rapid innovation, to better serve its institutional and corporate clients [3][4] Company Overview - Oppenheimer & Co. Inc. is a subsidiary of Oppenheimer Holdings Inc., providing a comprehensive range of wealth management, securities brokerage, and investment banking services [4] - The healthcare franchise, including biotechnology, pharmaceuticals, and medical technology, has been a core area of expertise for Oppenheimer [3]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - All content published by Proactive is edited and authored by humans, ensuring adherence to best practices in content production and search engine optimization [5]

Core Viewpoint - T-Mobile US Inc (NASDAQ:TMUS) is experiencing a decline in stock price following a downgrade by Oppenheimer, which cited slowing industry subscriber growth as a concern for the company's ability to meet subscriber and free cash flow estimates [1]. Stock Performance - T-Mobile's stock has been volatile, reaching a one-year low of $199.41 on November 6 after peaking at $276.49 in March. The stock is down approximately 5% year-to-date [2]. Options Trading Activity - Options traders are showing bullish sentiment, with a 10-day call/put volume ratio of 3.94, indicating significant buying activity. This ratio is the highest compared to all readings from the past year. Additionally, T-Mobile's put/call open interest ratio of 0.45 is in the lowest percentile of its annual range, further reflecting a positive outlook [3]. Volatility Expectations - T-Mobile's stock has historically exceeded options traders' volatility expectations, as indicated by a Schaeffer's Volatility Scorecard (SVS) rating of 91 out of 100 [4].